Immunotoxin Therapy for Lung Cancer  

作　　者：Li-Yi Xie Hai-Lan Piao Min Fan Zhen Zhang Chen Wang Darell D Bigner Xu-Hui Bao 

机构地区：[1]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China [2]Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China [3]Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA [4]Department of Medicine, China-Japan Friendship Hospital, Beijing 100029, China

出　　处：《Chinese Medical Journal》2017年第5期607-612,共6页中华医学杂志（英文版）

基　　金：The work was supported by grants from the Young Scientists Fund from the National Natural Science Foundation of China （No. 81401896）, and the Pujiang Talent Program from Shanghai Municipal Human Resource Bureau and Shanghai Science and Technology Committee （No. 14PJ1402000）.

摘　　要：INTRODUCTIONLung cancer is the leading cause for cancer-related deaths in both genders throughout the world. In the United States alone, there were 224,390 estimated new lung cancer cases and 158,080 estimated deaths in 2016.INTRODUCTIONLung cancer is the leading cause for cancer-related deaths in both genders throughout the world. In the United States alone, there were 224,390 estimated new lung cancer cases and 158,080 estimated deaths in 2016.

关 键 词：IMMUNOTHERAPY IMMUNOTOXINS Lung Neoplasms Molecular Targeted Therapy 

分 类 号：R[医药卫生]